Employers across the United States are reportedly cutting insurance coverage for weight-loss drugs like Ozempic and Wegovy.
The semaglutide injections have surged in popularity over recent months due to their ability to help users’ lose weight quickly.
However, soaring consumer demand has caused the weight-loss drugs’ prices to increase in turn, costing employers huge sums on their insurance plans.
Recent figures place the pricing for the aforementioned semaglutide injections at approximately $1,350 a month per patient.
